Found "Public health policy": 1,044 results
Sort by
Last updated

Using capability index to determine a value for money of the AIDS Competence Process in Thailand

The scientific information to support the causal relationship between input/output and outcome/impact of HIV prevention is inadequate and fragmented. A properly conducted economic evaluation could present reasoned and justifiable arguments as to why more or fewer resources should be directed towards particular HIV prevention interventions. However,

Cost-Utility Analysis of Acetylcholinesterase inhibitors in the Treatment of Mild to Moderate Alzheimer’s disease (in Thai language)

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

For Big Drug Companies, a Headache Looms

WASHINGTON — It would seem a business executive’s dream: legally pay a competitor to keep its product off the market for years.Congress has failed to stop it, and for more than a decade generic drug makers and big-name pharmaceutical companies have been winning court rulings that allowed it.Until th

Economic evaluation of drug treatments in patients with Chronic Hepatitis B (CHB) (in Thai language)

The objective of this study is to determine the economic evaluation of the treatment of chronic hepatitis B by using drugs that are currently available in Thailand, and to analyze the budget impact in listing drugs with cleared health economic evaluation into the National List of Essential Medicines.  01-340-2552

Drug-resistant HIV ‘on increase’ in sub-Saharan Africa

Drug-resistant HIV has been increasing in parts of sub-Saharan Africa over the last decade, according to experts writing in the Lancet.Studies on 26,000 untreated HIV-positive people in developing countries were reviewed by the team.They said resistance could build up if people fail to stick to drug

Research for development of health benefit package under universal coverage scheme

Since the Subcommittee for Development of Benefits and Service system under the Universal Coverage Scheme, the National Health Security Office considers that there are health measures not included in the health benefit package under the universal coverage scheme. Some measures are already in the benefits package, but they are expensive and service

Cost-benefit analysis of prenatal screening and diagnosis for Down syndrome in Thailand (in Thai language)

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

The debate over the price of the vaccine against HPV has become intense

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

Priority-setting in the journey towards universal health coverage

Welcome to iDSI, the international Decision Support Initiative. We provide a platform for supporting low and middle income country (LMIC) policymakers in making better use of healthcare resources to generate maximum health, in their journeys towards universal health coverage (UHC).

Washington DC: Improving the Use of Economic Evaluation for Global Health Funders

As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev
10 / Page